The DCGI approval has come after the Subject Expert Committee of the Central Drugs Standard Control Organization recommended granting regular market approval to Covishield and Covaxin, subject to certain conditions.
January 27, 2022
The Kitex group of companies had, in its petition filed last month, told the court that they have purchased the vaccine doses to be administered to its employees.
December 3, 2021
New Delhi, Nov 19 : As of now as many as 110 countries have recognized India’s Covid vaccines…
November 19, 2021
New Delhi, Oct 25 : Serum Institute of India (SII) on Monday sought regular marketing authorisation for Covid…
October 26, 2021
The move came as a reciprocity of the UK's decision that people vaccinated with Covishield in India will have to meet the strict mandatory quarantine rules while visiting the UK.
October 8, 2021
In response to concerns that people from the United Kingdom may be denied entry when traveling to the EU, Keersmaecker said the European Commission is working to solve the problem.
July 4, 2021
Chandra alleged that after taking the vaccine he has become more prone to the virus as his platelet count has been reduced by half.
May 31, 2021
The Bhutanese king has already conveyed that though India is a reliable friend but it won't pressure India over the vaccine and would instead approach other countries for the second dose of AstraZeneca.
May 22, 2021
The district health department said on Tuesday that it was holding back Covishield doses for people in the 18-44 age group due to limited allocation of the vaccine by the state
May 12, 2021
COVID-19 Vaccine: Serum Institute issues clarification on Covishield pricing, says Govt Procurement is at ‘far Lower Price’
"Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.
April 25, 2021
More than 21,000 people tested positive for COVID-19 after taking the first dose of either Covishield or Covaxin, while over 5,500 contracted the infection after taking the second dose, the Centre said on Wednesday.
April 22, 2021
Protection enhanced if the second dose of COVISHIELD is administered between 6-8 weeks
March 22, 2021
Doctors of Delhi’s premier RML Hospital have shot a letter to the hospital superintendent saying they do not want to take the Bharat Biotech vaccine – Covaxin – and would instead prefer the Covishield vaccine of Serum Institute of India.
January 16, 2021
The Centre has asked the Bharat Biotech to supply around 55 lakh doses to 12 centres before 14 January.
January 12, 2021
Could seek govt nod for limited use of ‘Covishield’ in December, may cost Rs 500-600: Serum CEO
November 20, 2020
Both Pfizer and Moderna’s COVID-19 vaccines, which are waiting for the approval of the regulatory body, are based on mRNA technology.
November 20, 2020
The permission was granted after the Serum institute satisfied certain requirements sought by the Drug Controller in the design of the proposal.
August 4, 2020